Your browser doesn't support javascript.
loading
Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung.
Nicholson, Andrew G; Torkko, Kathleen; Viola, Patrizia; Duhig, Edwina; Geisinger, Kim; Borczuk, Alain C; Hiroshima, Kenzo; Tsao, Ming S; Warth, Arne; Lantuejoul, Sylvie; Russell, Prudence A; Thunnissen, Erik; Marchevsky, Alberto; Mino-Kenudson, Mari; Beasley, Mary Beth; Botling, Johan; Dacic, Sanja; Yatabe, Yasushi; Noguchi, Masayuki; Travis, William D; Kerr, Keith; Hirsch, Fred R; Chirieac, Lucian R; Wistuba, Ignacio I; Moreira, Andre; Chung, Jin-Haeng; Chou, Teh Ying; Bubendorf, Lukas; Chen, Gang; Pelosi, Giuseppe; Poleri, Claudia; Detterbeck, Frank C; Franklin, Wilbur A.
Afiliação
  • Nicholson AG; Royal Brompton and Harefield National Health Service Foundation Trust and National Heart and Lung Institute, Imperial College, London/United Kingdom. Electronic address: a.nicholson@rbht.nhs.uk.
  • Torkko K; University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Viola P; Royal Brompton and Harefield National Health Service Foundation Trust and National Heart and Lung Institute, Imperial College, London/United Kingdom.
  • Duhig E; Sullivan Nicolaides Pathology, Taringa, Queensland, Australia.
  • Geisinger K; University of Mississippi Medical Center, Jackson, Mississippi.
  • Borczuk AC; Weill Cornell Medicine, New York, New York.
  • Hiroshima K; Tokyo Women's Medical University, Yachiyo/Japan.
  • Tsao MS; Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.
  • Warth A; Heidelberg University Hospital, Heidelberg, Germany.
  • Lantuejoul S; Cancer Institute Léon Bérard, Lyon, France.
  • Russell PA; St. Vincent's Pathology, Fitzroy, Victoria, Australia.
  • Thunnissen E; VU University Medical Center, Amsterdam, The Netherlands.
  • Marchevsky A; Cedars-Sinai Medical Center, Los Angeles, California.
  • Mino-Kenudson M; Massachusetts General Hospital, Boston, Massachusetts.
  • Beasley MB; Mount Sinai Medical Center, New York, New York.
  • Botling J; Uppsala University, Uppsala, Sweden.
  • Dacic S; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Yatabe Y; Aichi Cancer Center, Nagoya, Japan.
  • Noguchi M; University of Tsukuba, Tsukuba, Japan.
  • Travis WD; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kerr K; Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Hirsch FR; University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Chirieac LR; Harvard Medical School, Boston, Massachusetts.
  • Wistuba II; M. D. Anderson, Houston, Texas.
  • Moreira A; New York University Langone Medical Center, New York, New York.
  • Chung JH; Seoul National University Bundang Hospital, Seoul, Republic of Korea.
  • Chou TY; Taipei Veterans General Hospital, Taipei, Republic of China.
  • Bubendorf L; University Hospital Basel, Basel, Switzerland.
  • Chen G; Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • Pelosi G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Poleri C; Buenos Aires, Argentina.
  • Detterbeck FC; Department of Thoracic Surgery, Yale University, New Haven, Connecticut.
  • Franklin WA; University of Colorado Anschutz Medical Campus, Aurora, Colorado.
J Thorac Oncol ; 13(2): 205-217, 2018 02.
Article em En | MEDLINE | ID: mdl-29127023
ABSTRACT
Multiple tumor nodules are seen with increasing frequency in clinical practice. On the basis of the 2015 WHO classification of lung tumors, we assessed the reproducibility of the comprehensive histologic assessment to distinguish second primary lung cancers (SPLCs) from intrapulmonary metastases (IPMs), looking for the most distinctive histologic features. An international panel of lung pathologists reviewed a scanned sequential cohort of 126 tumors from 48 patients and recorded an agreed set of histologic features, including tumor typing and predominant pattern of adenocarcinoma, thereby opining whether the case was SPLC, IPM, or a combination thereof. Cohen κ statistics of 0.60 on overall assessment of SPLC or IPM indicated a good agreement. Likewise, there was good agreement (κ score 0.64, p < 0.0001) between WHO histologic pattern in individual cases and SPLC or IPM status, but the proportions diversified for histologic pattern and SPLC or IPM status (McNemar test, p < 0.0001). The strongest associations for distinguishing between SPLC and IPM were observed for nuclear pleomorphism, cell size, acinus formation, nucleolar size, mitotic rate, nuclear inclusions, intraalveolar clusters, and necrosis. Conversely, the associations for lymphocytosis, mucin content, lepidic growth, vascular invasion, macrophage response, clear cell change, acute inflammation keratinization, and emperipolesis did not reach significance with tumor extent. Comprehensive histologic assessment is recommended for distinguishing SPLC from IPM with good reproducibility among lung pathologists. In addition to main histologic type and predominant patterns of histologic subtypes, nuclear pleomorphism, cell size, acinus formation, nucleolar size, and mitotic rate strongly correlate with pathologic staging status.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variações Dependentes do Observador / Neoplasias Pulmonares Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Variações Dependentes do Observador / Neoplasias Pulmonares Limite: Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article